X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (50) 50
oncology (40) 40
index medicus (39) 39
cancer (30) 30
female (30) 30
male (30) 30
aged (29) 29
chemotherapy (21) 21
middle aged (21) 21
adult (18) 18
life sciences (16) 16
aged, 80 and over (14) 14
surgery (12) 12
analysis (10) 10
prognosis (10) 10
retrospective studies (10) 10
tumors (10) 10
antineoplastic agents - therapeutic use (9) 9
survival (9) 9
treatment outcome (9) 9
elderly (8) 8
care and treatment (7) 7
disease-free survival (7) 7
expression (7) 7
health aspects (7) 7
hematology, oncology and palliative medicine (7) 7
metastasis (7) 7
prospective studies (7) 7
prostate cancer (7) 7
review (7) 7
young adult (7) 7
aged patients (6) 6
colorectal cancer (6) 6
medicine, general & internal (6) 6
sarcoma (6) 6
therapy (6) 6
adjuvant chemotherapy (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
breast neoplasms - drug therapy (5) 5
diagnosis (5) 5
drug therapy (5) 5
france (5) 5
gastroenterology & hepatology (5) 5
management (5) 5
medical research (5) 5
metastases (5) 5
patients (5) 5
progression (5) 5
quality of life (5) 5
recurrence (5) 5
[ sdv.can ] life sciences [q-bio]/cancer (4) 4
[sdv.can]life sciences [q-bio]/cancer (4) 4
administration, oral (4) 4
adolescent (4) 4
antineoplastic agents - adverse effects (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
bevacizumab (4) 4
breast-cancer (4) 4
cancer patients (4) 4
case report (4) 4
child (4) 4
cisplatin (4) 4
cohort studies (4) 4
combined modality therapy (4) 4
development and progression (4) 4
diagnosis, differential (4) 4
docetaxel (4) 4
france - epidemiology (4) 4
guidelines (4) 4
hematology (4) 4
medicine & public health (4) 4
neoplasm metastasis (4) 4
neoplasms. tumors. oncology. including cancer and carcinogens (4) 4
older people (4) 4
ovarian cancer (4) 4
receptors, androgen - genetics (4) 4
research (4) 4
risk factors (4) 4
surveys and questionnaires (4) 4
survival rate (4) 4
treatment (4) 4
trial (4) 4
age (3) 3
age factors (3) 3
agranulocytosis - chemically induced (3) 3
angiosarcoma (3) 3
antibodies, monoclonal - therapeutic use (3) 3
breast cancer (3) 3
cancer therapies (3) 3
cancer-patients (3) 3
carboplatin - administration & dosage (3) 3
carcinoma (3) 3
cell line, tumor (3) 3
clinical trials, phase ii as topic (3) 3
cobalamin deficiency (3) 3
colon-cancer (3) 3
combination (3) 3
diagnostic systems (3) 3
differentiation (3) 3
disease progression (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 2014, Volume 9, Issue 12, p. e115060
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 05/2017, Volume 104, pp. S39 - S42
Metastatic or recurrent cervical cancer/treatment The prognosis of metastatic or recurrent cervical cancer remains dismal. The poor chemosensitivity of this... 
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2014, Volume 50, Issue 18, pp. 3107 - 3115
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 1330 - 1330
Abstract Introduction Chemotherapy-induced anaemia (CIA) is a frequent complication of patients (pts) with cancer, associated with fatigue and impaired quality... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2014, Volume 32, Issue 31_suppl, pp. 217 - 217
217 Background: Chemotherapy-induced anaemia (CIA) is a frequent complication of patients with cancer. The ORHEO (place of biOsimilaRs in the therapeutic... 
Journal Article
Cancer Research, ISSN 0008-5472, 10/2014, Volume 74, Issue 19 Supplement, pp. 2117 - 2117
Journal Article
Oncologist, ISSN 1083-7159, 01/2019, Volume 24, Issue 1, pp. 62 - 68
BACKGROUND:Group-based trajectory modeling is particularly important to identify subgroups of patients with pathological cognitive changes after cancer... 
Life Sciences | Human health and pathology | Cancer | Psychiatrics and mental health
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 03/2019, Volume 37, Issue 8, pp. 658 - 658
PURPOSENo standard adjuvant treatment currently is recommended in localized biliary tract cancer (BTC) after surgical resection. We aimed to assess whether... 
CETUXIMAB | MULTICENTER | CLINICAL-TRIAL | CISPLATIN | ONCOLOGY | OPEN-LABEL | COMBINATION | CARCINOMA
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2014, Volume 32, Issue 4_suppl, pp. 212 - 212
212 Background: Spironolactone is an effective drug to treat arterial hypertension as well as fluid retention and hypokalemia. Recently, some data suggested... 
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2012, Volume 48, Issue 16, pp. 3027 - 3035
Abstract Aims A minority of patients with advanced sarcoma achieve prolonged progression free survival (PFS) with insulin growth factor type 1 receptor... 
Hematology, Oncology and Palliative Medicine | Sarcoma | Nuclear IGF-1R | IGF-1R monoclonal antibody | ACTIVATION | CP-751,871 | PHASE-II | TUMOR-CELLS | COMBINATION | CANCER | GENE | ONCOLOGY | FACTOR SYSTEM | FACTOR-I RECEPTOR | XENOGRAFTS | Immunohistochemistry | Osteosarcoma - drug therapy | Predictive Value of Tests | Receptor, IGF Type 1 - metabolism | Receptor, IGF Type 1 - antagonists & inhibitors | Sarcoma - immunology | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Antibodies, Monoclonal - therapeutic use | Ki-67 Antigen - metabolism | Male | Antineoplastic Agents - therapeutic use | Bone Neoplasms - metabolism | Patient Selection | Young Adult | Receptor, Epidermal Growth Factor - metabolism | Cell Nucleus - metabolism | Insulin-Like Growth Factor Binding Protein 3 - metabolism | Time Factors | Sarcoma - mortality | Biomarkers, Tumor - metabolism | Adult | Female | Bone Neoplasms - drug therapy | Biomarkers, Tumor - antagonists & inhibitors | France | Child | Osteosarcoma - metabolism | Sarcoma, Ewing - metabolism | Kaplan-Meier Estimate | Treatment Outcome | Sarcoma - drug therapy | Sarcoma, Ewing - drug therapy | Sarcoma - metabolism | Disease-Free Survival | Biopsy | Adolescent | Receptor, IGF Type 1 - immunology | Cell Line, Tumor | Aged | Biomarkers, Tumor - immunology | Antimitotic agents | Monoclonal antibodies | Development and progression | Antineoplastic agents | Biopharmaceutics | Sarcoma, Ewing | Life Sciences | Osteosarcoma | Ki-67 Antigen | Tumor Markers, Biological | Receptor, IGF Type 1 | Antineoplastic Agents | Antibodies, Monoclonal | Bone Neoplasms | Receptor, erbB-2 | Insulin-Like Growth Factor Binding Protein 3 | Cell Nucleus | Receptor, Epidermal Growth Factor | Cancer
Journal Article
Journal Article
The Oncologist, ISSN 1083-7159, 08/2019, Volume 24, Issue 8, pp. e775 - e783
Background Soft tissue sarcomas are rare and heterogenous tumors that are hard to diagnose. The aim of this study was to evaluate local practices and... 
Soft tissue tumors | Diagnostic management | Conformity to clinical guidelines | Sarcomas | DIAGNOSIS | ONCOLOGY | SARCOMA PATIENTS | ADHERENCE
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.